Post

New research · Obstetrics & Gynecology
The New England journal of medicine · 1w
Randomized trialThe New England journal of medicine · 2024

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.

Marie Plante, Janice S Kwon, Sarah Ferguson … CX.5 SHAPE Investigators
Read paper
Obstetrics & GynecologyRandomized trial

Simple hysterectomy was noninferior to radical hysterectomy for low-risk cervical cancer

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.

Marie Plante … CX.5 SHAPE Investigators
The New England journal of medicine · 2024
Background

Retrospective data suggest that the incidence of parametrial infiltration is low in patients with early-stage low-risk cervical cancer, which raises questions regarding the need for radical hysterectomy in these patients.

Methods

We conducted a multicenter, randomized, noninferiority trial comparing radical hysterectomy with simple hysterectomy including lymph-node assessment in patients with low-risk cervical cancer (lesions of ≤2 cm with limited stromal invasion).

n = 700 patients
Results

similarly low rate of cancer returning in the pelvis after simpler, less extensive surgery

absolute difference 0.35 (95% CI -1.62 to 2.32)
null = 0-1.622.32
CI crosses the null - not significant
More results

Among 700 patients who underwent randomization (350 in each group), the majority had tumors that were stage IB 1 according to the 2009 International Federation of Gynecology and Obstetrics (Federation of Gynecology and Obstetrics) criteria (91.7%), that had squamous-cell histologic features (61.7%), and that were grade 1 or 2 (59.3%).

More results

Results were similar in a per-protocol analysis.

“
Conclusion · 1 of 2

In patients with low-risk cervical cancer, simple hysterectomy was not inferior to radical hysterectomy with respect to the 3-year incidence of pelvic recurrence and was associated with a lower risk of urinary incontinence or retention.

Conclusion · 2 of 2

(Funded by the Canadian Cancer Society and others; ClinicalTrials.gov number, NCT01658930.).

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Randomized Trial
hazard ratio 0.43
cancer was much less likely to grow or come back during follow-up
Study
120
essential learning goals international experts agreed every global surgery training program should cover
Randomized Trial
-2.3 percentage points
the chance of staying cancer-free for 3 years was higher with biopsy only
Cohort Study
HR 0.85
The hazard of death was similar with adjuvant chemoradiotherapy versus radiotherapy alone.
Randomized Trial
HR 0·42
for p53-abnormal tumors, combined treatment nearly halved the risk of cancer returning
Study
96.2% (90% CI, 85.9%-97.9%)
high percentage of patients whose hormone levels returned to normal, allowing treatment to stop
Cohort Study
33.3%
Among pregnant women with anemia, a higher percentage had babies born early
Cohort Study
26.4%
women with diabetes during pregnancy developed high blood pressure 5 months after birth